Pregnancy at a later age with the help of oocyte donation;Zwangerschap op oudere leeftijd door middel van eiceldonatie

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 47, 2006, Pages 2591-2595

  Kortman, M ^a   De Wert, G M W R ^b   Fauser, B C J M ^a   Macklon, N S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GONADOTROPIN; PROGESTERONE;

CESAREAN SECTION; CHILDBIRTH; FERTILITY; HEALTH HAZARD; HUMAN; MATERNAL HYPERTENSION; OOCYTE DONATION; OVARY CYCLE; PREECLAMPSIA; PREGNANT WOMAN; PREMATURITY; REVIEW; SOCIAL PSYCHOLOGY;

FEMALE; HUMANS; INFERTILITY, FEMALE; MATERNAL AGE; MIDDLE AGED; OOCYTE DONATION; PATIENT SELECTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RISK ASSESSMENT;

EID: 33845311172     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Beckers NGM, Macklon NS, Eijkemans MJC, Fauser BCJM. Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril. 2002;78:291-7.
2. Velde ER te, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141-54.
3. Cohen MA, Lindheim SR, Sauer MV. Donor age is paramount to success in oocyte donation. Hum Reprod. 1999;14:2755-8.
4. Navot D, Drews MR, Bergh PA, Guzman I, Karstaedt A, Scott jr RT, et al. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril. 1994;61:97-101.
5. Kwaliteitsinstituut voor de gezondheidszorg CBO (CBO). Modelreglement Embryowet. Utrecht: CBO; 2003.
6. Commissie Herziening Planningsbesluit. Het Planningsbesluit IVF. Publicatienr 1997/03. Rijswijk: Gezondheidsraad; 1997.
7. Lutjen P, Trounson A, Leeton J, Findlay J, Wood C, Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature. 1984;307:174-5.
8. Eerste Kamer. Vergaderjaar 2001-2002. Embryowet, nr 47 [wet houdende regels inzake handelingen met geslachtscellen en embryo's].
9. Eerste Kamer. Vergaderjaar 2000-2001, 23207, nr 201 [wet donorgegevens kunstmatige bevruchting].
10. Schoot BCh, Vemer HM, Fauser BCJM. Gonadotrofinen en inductie van (super)ovulatie. Ned Tijdschr Geneeskd. 1992;136:217-20.
11. Macklon NS, Fauser BCJM. Terugplaatsing van slechts één embryo bij in-vitiofertilisatie. Ned Tijdschr Geneeskd. 2003;147:1301-4.
12. Burton G, Abdalla HI, Kirkland A, Studd JWW. The role of oocyte donation in women who are unsuccessful with in-vitro fertilization treatment. Hum Reprod. 1992;7:1103-5.
13. Abdalla HI, Billett A, Kan AKS, Baig S, Wren M, Korea L, et al. Obstetric outcome in 232 ovum donation pregnancies. Br J Obstet Gynaecol. 1998;105:332-7.
14. Yaron Y, Ochshorn Y, Amit A, Kogosowski A, Yovel I, Lessing JB. Oocyte donation in Israel: a study of 1001 initiated treatment cycles. Hum Reprod. 1998;13:1819-24.
15. Salha O, Sharma V, Dada T, Nugent D, Rutherford AJ, Tomlinson AJ, et al. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod. 1999;14:2268-73.
16. Söderström-Antilla V, Sajaniemi N, Tiitinen A, Hovatta O. Health and development of children born after oocyte donation compared with that of those born after in-vitro fertilization, and parents' attitudes regarding secrecy. Hum Reprod. 1998;13:2009-15.
17. Katwijk C van, Peeters LLH. Clinical aspects of pregnancy after the age of 35 years: a review of the literature. Hum Reprod Update. 1998;4:185-94.
18. Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman DE, Slater CC, et al. Pregnancy outcome in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA. 2002;288:2320-3.
19. Antinori S, Gholami GH, Versaci C, Cerusico F, Dani L, Antinori M, et al. Obstetric and prenatal outcome in menopausal women: a 12-year clinical study. Reprod Biomed Online. 2002;6:257-61.
20. Michalas S, Loutradis D, Drakakis P, Milingos S, Papageorgiou J, Kallianidis K, et al. Oocyte donation to women over 40 years of age: pregnancy complications. Eur J Obstet Gynecol Reprod Biol. 1996;64:175-8.
21. Sheffer-Mimouni G, Mashiach S, Dor J, Levran D, Seidman DS. Factors influencing the obstetric and perinatal outcome after oocyte donation. Hum Reprod. 2002;17:2636-40.
22. Wiggins DA, Main E. Outcomes of pregnancies achieved by donor egg in vitro fertilization. A comparison with standard in vitro fertilization pregnancies. Am J Obstet Gynecol. 2005;192:2002-6.
23. Koopersmith TB, Lindheim SR, Lobo RA, Paulson RJ, Sauer MV. Outcomes of high-order implantations in women undergoing ovum donation. J Matern Fetal Med. 1997;6:268-72.
24. Bowman MC, Saunders DM. Community attitudes to maternal age and pregnancy after assisted reproductive technology: too old at 50 years? Hum Reprod. 1994;9:167-71.
25. Römkens M, Gordijn B, Verhaak CM, Meuleman EJH, Braat DDM. Geen onderbouwing voor maximale leeftijdsgrens voor mannen bij in-vitrofertilisatie of intracytoplasmatische sperma-injectie. Ned Tijdschr Geneeskd. 2005;149:992-5.
26. Wert GMWR de. De postmenopauze: speeltuin voor de voortplantingstechnologie? Enkele ethische overwegingen. In: Slager E, Schoemaker J, Gerris JMR, redacteuren. Fertiliteitsonderzoek en behandeling anno 1994. Oss: Organon; 1994. p. 402-16.
27. Sauer MV, Kavic SM. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online. 2006;12:153-62.
28. KNMG; Commissie Medische Ethiek. IVF op latere leeftijd. Med Contact. 1996;51:620-7.
29. Velde ER te. Zwangerschap in de 21e eeuw; steeds later, steeds kunstmatiger [oratie]. Utrecht: Universiteit Utrecht; 1991.